Comments
Loading...

Inozyme Pharma

INZYNASDAQ
Logotipo presentado por Benzinga Data
$3.95
2.53178.17%
al cierre: -
$3.94
-0.01-0.25%
After hour: 7:56 PM EDT
Los beneficios de Q1 2025 se publicaron el mié may 14th, antes de la apertura del mercado
Inozyme Pharma (INZY) announced it will be acquired by Biomarin Pharmaceutical (BMRN) on Friday, May 16, 2025 for $270.0M paid in cash

No Unusual Options Activity in the Last 90 Days